Mayo's most recent trade in Broadwind Inc was a trade of 8,348 Common Stock done at an average price of $4.6 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 01 Jul 2026 | 8,348 | 133,438 (0%) | 0% | 4.6 | 38,818 | Common Stock |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 19,036 | 25,500 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 19,036 | 200,118 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 9,903 | 44,536 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 1,743 | 764 | - | - | Dividend Equivalent Rights | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 1,743 | 181,082 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 1,282 | 2,508 | - | - | Dividend Equivalent Rights | |
| Allogene Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 144,400 | 144,400 | - | - | Stock Option (Right to buy) | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 50,000 | 431,130 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 16,875 | 18,640 (0%) | 0% | - | Common Stock | |
| Happen Inc | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 13,715 | 13,715 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2026 | 1,853 | 14,824 | - | - | Phantom Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Grant, award, or other acquisition of securities at price $ 3.68 per share. | 28 May 2026 | 8,231 | 125,090 (0%) | 0% | 3.7 | 30,249 | Common Stock |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.96 per share. | 26 May 2026 | 753 | 116,859 (0%) | 0% | 4.0 | 2,982 | Common Stock |
| EPAM | Richard Michael Mayoras | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 2,132 | 12,825 (0%) | 0% | 0 | EPAM Common Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 15 May 2026 | 1,607 | 118,932 (0%) | 0% | 4.5 | 7,264 | Common Stock |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.79 per share. | 15 May 2026 | 1,320 | 117,612 (0%) | 0% | 3.8 | 5,003 | Common Stock |
| Capital One | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2026 | 1,294 | 67,911 (0%) | 0% | 0 | Common Stock | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 22,898 | 22,898 | - | - | Restricted Stock Units | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.53 per share. | 01 May 2026 | 1,015 | 22,868 (0%) | 0% | 38.5 | 39,108 | Common Stock |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Sale of securities on an exchange or to another person at price $ 17.02 per share. | 12 Mar 2026 | 7,239 | 1,765 (0%) | 0% | 17.0 | 123,208 | Common Stock |
| Kyverna Therapeutics Inc | Mayo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 20,631 | 34,633 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 20,631 | 179,339 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 8,482 | 55,264 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 2,572 | 158,708 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 2,572 | 1,225 | - | - | Dividend Equivalent Rights | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,381 | 3,798 | - | - | Dividend Equivalent Rights | |
| Allogene Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 95,400 | 95,400 | - | - | Restricted Stock Unit | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 381,130 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 50,000 | 381,130 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Science Applications Intl Corp | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 103.43 per share. | 04 Jun 2025 | 1,644 | 9,571 (0%) | 0% | 103.4 | 170,039 | Common Stock |
| Happen Inc | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 2,863 | 12,539 | - | - | Phantom Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.72 per share. | 27 May 2025 | 711 | 120,539 (0%) | 0% | 1.7 | 1,223 | Common Stock |
| EPAM | Richard Michael Mayoras | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 1,372 | 10,693 (0%) | 0% | 0 | EPAM Common Stock | |
| Capital One | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2025 | 358 | 66,575 (0%) | 0% | - | Common Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 12,356 | 122,339 (0%) | 0% | 0 | Common Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 15 May 2025 | 1,089 | 121,250 (0%) | 0% | 1.9 | 2,047 | Common Stock |
| Capital One | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 1,241 | 66,217 (0%) | 0% | 0 | Common Stock | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 39,077 | 39,077 | - | - | Stock Options (Right to Buy) | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 01 May 2025 | 1,200 | 23,883 (0%) | 0% | 66.7 | 80,052 | Common Stock |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 25 Apr 2025 | 1,193 | 109,983 (0%) | 0% | 1.5 | 1,778 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2025 | 4,823 | 25,083 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,792 | 4,792 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 2,383 | 9,004 (0%) | 0% | - | Common Stock | |
| Geo Grp Inc | Terry P. Mayotte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 5,719 | 25,877 (0%) | 0% | 0 | Restricted Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 29,174 | 124,269 (0%) | 0% | 0 | Common Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 26 Feb 2025 | 13,093 | 111,176 (0%) | 0% | 1.6 | 20,556 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Sale of securities on an exchange or to another person at price $ 81.43 per share. | 15 Jan 2025 | 5,000 | 20,260 (0%) | 0% | 81.4 | 407,150 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.04 per share. | 15 Jan 2025 | 5,000 | 25,260 (0%) | 0% | 63.0 | 315,200 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 5,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 06 Dec 2024 | 56,490 | 331,130 | - | 5.5 | 310,791 | Class A Common Stock |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 20 Nov 2024 | 42,721 | 387,620 | - | 5.0 | 213,622 | Class A Common Stock |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Sale of securities on an exchange or to another person at price $ 4.66 per share. | 12 Nov 2024 | 88,311 | 430,341 | - | 4.7 | 411,838 | Class A Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 11,150 | 5,000 | - | - | Stock Options (Right to Buy) | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.04 per share. | 16 Jul 2024 | 11,150 | 29,578 (0%) | 0% | 63.0 | 702,896 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Sale of securities on an exchange or to another person at price $ 83.46 per share. | 16 Jul 2024 | 9,318 | 20,260 (0%) | 0% | 83.5 | 777,680 | Common Stock |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,115 | 51,834 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 5,052 | 46,782 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 5,052 | 155,320 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 1,174 | 3,234 | - | - | Dividend Equivalent Rights | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 816 | 156,136 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 816 | 2,417 | - | - | Dividend Equivalent Rights | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 27,760 | 518,652 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 27,760 | 0 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 27,760 | 27,760 | - | - | Restricted Stock Units | |
| Happen Inc | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,480 | 24,480 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 191,082 | 191,082 | - | - | Stock Option (Right to buy) | |
| Science Applications Intl Corp | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,451 | 7,927 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 9,379 | - | - | Phantom Stock | |
| EPAM | Richard Michael Mayoras | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,051 | 9,321 (0%) | 0% | 0 | EPAM Common Stock | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.42 per share. | 28 May 2024 | 666 | 95,095 (0%) | 0% | 4.4 | 2,944 | Common Stock |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 10,903 | 95,761 (0%) | 0% | 0 | Common Stock | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.71 per share. | 03 May 2024 | 578 | 18,428 (0%) | 0% | 68.7 | 39,714 | Common Stock |
| Capital One | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,658 | 64,953 (0%) | 0% | 0 | Common Stock | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 30,843 | 30,843 | - | - | Stock Options (Right to Buy) | |
| Broadwind Inc | Gilbert W. Mayo | Pres., Broadwind Ind. Solution | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. | 25 Apr 2024 | 1,251 | 84,858 (0%) | 0% | 2.1 | 2,602 | Common Stock |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 1,454 | 19,006 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Sale of securities on an exchange or to another person at price $ 122.96 per share. | 05 Mar 2024 | 3,135 | 6,621 (0%) | 0% | 123.0 | 385,480 | Common Stock |
| Geo Grp Inc | Terry P. Mayotte | Director | 01 Mar 2024 | 11,166 | 31,010 (0%) | 0% | 0 | Restricted Stock | ||
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,679 | 3,679 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Stephen L. Mayo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,846 | 9,756 (0%) | 0% | 0 | Common Stock | |
| CarMax | Enrique N. Mayor-Mora | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 225 | 0 | - | - | Restricted Stock Units | |
| CarMax | Mayor-Mora N. Enrique | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 168 | 17,603 (0%) | 0% | - | Common Stock | |
| CarMax | Mayor-Mora Enrique N. | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.84 per share. | 28 Dec 2023 | 51 | 17,552 (0%) | 0% | 77.8 | 3,970 | Common Stock |
| Blend Labs Inc (Class A) | Mayopoulos Timothy J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 8,333 | 0 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | J. Mayopoulos Timothy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2023 | 8,333 | 8,333 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Timothy Mayopoulos J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 8,333 | 490,892 | - | - | Class A Common Stock | |
| Happen Inc | Timothy J. Mayopoulos | Director | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 31 Oct 2023 | 10,000 | 116,527 (0%) | 0% | 5.2 | 51,687 | Common Stock |
| Allogene Therapeutics Inc | Stephen L. Mayo | Director | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 07 Aug 2023 | 10,000 | 25,328 (0%) | 0% | 4.3 | 42,855 | Common Stock |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 19,036 | 57,397 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 12,678 | 150,268 (0%) | 0% | 0 | Common Stock | |
| Gap Inc | Mayo A. Shattuck | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 12,678 | 44,719 | - | - | Stock Units | |
| Gap Inc | Mayo A. Shattuck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,657 | 3,852 | - | - | Dividend Equivalent Rights |